However, our long-lived mice are slightly larger and consume about the same or slightly more food than the short-lived controls. Indeed, longlived systemic Irs2 +/− mice are more insulin sensitive and glucose tolerant than WT mice; however, long-lived brain-specific bIrs2 +/− and bIrs2 −/− mice are insulin resistant, hyperinsulinemic, and glucose intolerant. The mechanism responsible for this disparity is unknown. Regardless, our results point to the brain as the site where reduced insulin-like signaling can have a consistent effect to extend mammalian life span-as it does in C. elegans and D. melanogaster (1, 3).
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As mammals age, compensatory hyperinsulinemia usually develops to maintain glucose homeostasis and prevent the progression toward life-threatening type 2 diabetes (6); however, increased circulating insulin might have negative effects on the brain that can reduce life span (4, 21, 23) . By directly attenuating brain Irs2 signaling, an aging brain can be shielded from the negative effects of hyperinsulinemia that ordinarily develop with overweight and advancing age. Consistent with this hypothesis, moderate daily exercise, calorie restriction, and weight losswhich reduce circulating insulin-might increase life span by attenuating Irs2 signaling in the brain. Other strategies that improve peripheral insulin sensitivity, such as reduced growth hormone signaling, could have the same effect (5) . Indeed, human centenarians display increased peripheral insulin sensitivity and reduced circulating insulin concentrations (23) . Hence, we suggest that the Irs2 signaling cascade in the brain integrates the effects of peripheral nutrient homeostasis with life span. In Drosophila, Ptc inhibits the movement of Smo to the plasma membrane. Binding of Hh causes the internalization of Ptc from the plasma Fig. 4 . Loss of brain Irs2 stabilizes Sod2 in the postprandial brain. (A) Hypothalamic lysates were prepared from pairs of male siblings of the indicated genotype before (Fast) or after 2-hour feeding (Fed), resolved by SDS polyacrylamide gel electrophoresis, and immunoblotted with antibodies against Sod2 or FoxO1 (two independent experiments are shown). b-tubulin (shown for one experiment) was immunoblotted for all the experiments to confirm equivalent loading. Autoradiographs were quantified, and the ratio of intensities (Fed/Fast) for (B) Sod2 (n = 5) or (C) FoxO1 (n = 4) was calculated. Boxes show the median ratio (solid horizontal line) and the lower and upper quartiles; the Kruskal-Wallis nonparametric test was used to compare the groups across all genotypes (*P < 0.05).
membrane to vesicles, allowing Smo to translocate to the plasma membrane and activate downstream signaling (3, 4) . The discovery that protein components of primary cilia are required for Hh signaling suggested that subcellular localization has an important role in mammalian Hh signaling (5) . Primary cilia are cell surface projections found on most vertebrate cells that function as sensory "antennae" for signals (6) . Several components of the Hh pathway, including Smo and the Gli proteins, accumulate in primary cilia, and Smo is enriched in cilia upon stimulation with Shh (7, 8) .
We examined the dynamic subcellular localization of Ptc1 and Smo in mammalian cells with the use of novel antibodies to the two proteins ( fig.  S1 ). These antibodies allowed detection of endogenous Ptc1 and Smo in cultured mouse fibroblasts (NIH 3T3 cells) and mouse embryonic fibroblasts (MEFs), two Hh-responsive cell types (9) . Hh signaling was activated in NIH 3T3 cells by treatment with either Shh or SAG (Shh-agonist), a small molecule that directly binds and activates Smo (10) . Because ptc1 is itself a transcriptional target of Hh signaling, increases in Ptc1 protein levels can serve as a metric for pathway activation. Ptc1 protein levels began to rise by 4 hours and continued to increase until 24 hours after addition of Shh (Fig. 1A) . After stimulation of cells with Shh or SAG, endogenous Smo was enriched in primary cilia (Fig. 1B) . The mean fluorescence intensity of Smo in cilia began to increase as early as 1 hour after stimulation of cells with Shh or SAG (Fig. 1C and fig. S2 ). This likely represented relocalization from a cytoplasmic pool, because the total amount of Smo protein did not increase at this time point (Fig. 1A) .
To determine whether Ptc1 regulates the localization of Smo, we examined Smo localization in MEFs from ptc1 −/− mice (9). These cells showed constitutive activation of Hh target gene transcription ( fig. S3 ). Consistent with a role of Ptc1 in regulating Smo trafficking, Smo was constitutively localized to primary cilia in these cells even in the absence of Shh or SAG (Fig. 1, D and E) . Reintroduction of Ptc1 into these cells by means of a retrovirus suppressed Hh-pathway activity ( fig. S3 ) and prevented Smo accumulation in primary cilia (Fig. 1, D and E) . Thus, the regulation of Smo localization by Ptc1 is conserved from flies to mammals.
To understand how Ptc1 may regulate entry of Smo into the cilium, we examined the localization of Ptc1 in MEFs and mouse embryos. Endogenous Ptc1 was present in small amounts in MEFs, near the limit of detection by immunofluorescence. We therefore increased the amounts of Ptc1 protein by stimulating cells with SAG. Under these conditions, Ptc1 was highly enriched in primary cilia (Fig. 2A) . The ciliary localization of Ptc1 was confirmed in three additional ways. (Fig. 3A and figs. S10 and S14 ). Third and most important, endogenous Ptc1 was found in the cilia of mouse embryo mesoderm cells responsive to Shh (Fig. 2D and figs. S4 and S5 ) (1) .
Ptc1 staining in cross sections of embryonic day 9.5 (E9.5) embryos was detected in cells of the ventral neural tube, notochord, splanchnic mesoderm, and paraxial mesoderm, precisely the regions where Hh signaling is known to be active and Shh target genes such as ptc1 are highly expressed (Fig. 2C and fig. S4B) (1) . We focused on mesoderm cells because they are likely the cells that gave rise to the MEFs that we have analyzed in culture. Endogenous Ptc1 showed asymmetric localization to a domain surrounding the base of the cilium and in particles along the shaft of the cilium (Fig. 2D and figs. S4C and  S5 ). This localization pattern around the base and in a particulate pattern along the shaft of the cilium is similar to that seen in cultured fibroblasts (compare Fig. 2D and fig. S12 ). In embryo cells, there was more variability in the amount of Ptc1 in the shaft of cilia, a finding likely related to differences in the amount of Shh signal received by cells in the complex milieu of embryonic tissue. The concentration of Ptc1 at the base of primary cilia suggests a mechanism for how it may inhibit Smo activation. Transport of proteins in and out of primary cilia is thought to be regulated at their base, and Ptc1 could function at this location to inhibit a protein-trafficking step critical for Smo activation (11) .
Shh could inactivate Ptc1 by binding to it at the cilium and inducing its internalization, degradation, or movement to other regions of the plasma membrane. To determine whether Ptc1 at the cilium can bind to Shh, we produced a fluorescently labeled version of the N-terminal signaling fragment of Shh (ShhN-A594). Minute amounts of ShhN-A594, one-hundredth of those required to activate signaling, were added to live ptc1 −/− cells transfected with Ptc1-YFP and a marker for cilia, inversin fused to cyan fluorescent protein (inversin-CFP) (12) . Live cells were used because the interaction between Shh and Ptc1 does not survive fixation. ShhN-A594 concentrated at cilia containing Ptc1-YFP and colocalized with puncta of Ptc1-YFP (Fig. 3A and fig. S7 ). Ptc1 −/− cells expressing inversin-CFP alone did not bind ShhN-A594, and an excess of unlabeled ShhN prevented binding of ShhN-A594 ( fig. S7) .
We next asked whether the interaction of Shh with Ptc1 influences the localization of Ptc1. Ptc1 was concentrated at cilia after treatment of cells with SAG alone but not after treatment with Shh or a combination of Shh and SAG (Fig. 3B) . This suggested that Shh binding might trigger the removal of the Ptc1-Shh complex from the cilium, or that new Ptc1 produced in response to Shh was not localized in the cilium. To distinguish these possibilities, we induced the production of large amounts of Ptc1 in the cilia of NIH 3T3 cells with SAG treatment and then switched the cells to control medium or medium containing Shh (Fig. 3C ). Ptc1 levels in the cilium remained stable in the control, but Shh treatment caused a time-dependent disappearance of Ptc1 from the primary cilium ( Fig. 3C and fig. S8 ). The loss of Ptc1 from cilia was not associated with a decrease in total Ptc1 protein levels (fig. S11) and thus implied movement of Ptc1 from cilia to another location in the cell. This delocalization was only evident with the endogenous protein and not upon examination of transfected Ptc1-YFP, a far more abundant protein ( fig. S7B ).
We measured Ptc1 and Smo localization (Figs. 1 and 3 Ptc1 may regulate Smo localization through a small molecule (13) . Because Smo translocation to the primary cilium appears to be a critical step in its activation, a regulatory small molecule would be predicted to control this step. Naturally occurring oxysterols are good candidates for endogenous small molecules that regulate Smo function. Cellular sterol concentrations are important determinants of a cell's responsiveness to Shh, and oxysterols can activate Hh signaling (14-16). When we treated NIH 3T3 cells with activating concentrations of the oxysterol 20a-hydroxycholesterol, Smo rapidly translocated to the primary cilium with kinetics that were identical to those seen in cells treated with SAG or Shh (Fig. 4, A and B, and fig. S9 ). Treatment with 7b-hydroxycholesterol, an oxysterol that does not activate the Hh pathway, did not induce translocation of Smo. This result provides a specific molecular mechanism-Smo translocation to cilia-to explain how oxysterols regulate Hh signaling.
Cells treated with 20a-hydroxycholesterol also retained Ptc1 in cilia in a pattern similar to that seen in cells treated with SAG (Fig. 4, C and  D) . Thus, oxysterols appear to function not like Shh, by causing the removal of Ptc1 from cilia, but at a more downstream step to make Smo insensitive to the inhibitory effects of Ptc1. However, oxysterols function differently from SAG because they likely do not directly bind to Smo (16) .
Our results suggest that Ptc1 localization to primary cilia inhibits the Hh pathway by excluding Smo and also allows cilia to function as chemosensors for the detection of extracellular Shh. Binding of Shh to Ptc1 at primary cilia is coupled to pathway activation by the reciprocal movement of Ptc1 out of the cilia and Smo into the cilia, a process that may be mediated by oxysterols. Elucidating the molecular machinery that controls Ptc1 and Smo trafficking at primary cilia will likely provide new targets for modulation of this important pathway.
